Eyedentity
We develop clinically grounded AI solutions for eye health.
We focus on early detection and decision support, helping eye care professionals identify risk earlier and act with greater confidence. Our work combines medical expertise, long-term clinical data, and modern machine learning tools. The result is AI that fits real clinical workflows and addresses problems that matter in everyday practice.
MelAInoma
MelAInoma is an AI-based decision support tool for the early detection of uveal melanoma using retinal images.
For Opticians and Ophthalmologists
MelAInoma supports opticians and ophthalmologists by providing a risk assessment based on retinal images, helping reduce unnecessary referrals while maintaining high sensitivity for malignant cases.
Supporting - not replacing
The model is developed using unique, longitudinal clinical data and validated in peer-reviewed studies. MelAInoma is designed to integrate into existing imaging workflows and support clinical judgment, not replace it.
News and Updates
Peer-reviewed validation of MelAInoma
Recent studies demonstrate that MelAInoma significantly improves diagnostic accuracy compared to standard assessment, while reducing false referrals.The results are based on longitudinal clinical data and external validation.
Read the article
AI decision support in optometric practice
AI is becoming an important part of modern eye care.This article discusses how decision support tools can strengthen opticians’ clinical role and improve referral quality.
Read the article
Eyedentity at Optikmässan
Eyedentity will be speaking at Optikmässan.Friday 17 January, 11:45 - 12:45Lecture: AI support for early detection of ocular melanoma — Gustav Stålhammar, MD, PhD
Read more about the session
Management Team
Successful teams combine the different skillsets needed to solve the problem at hand. Our management team has a long experience in the fields needed to bring AI projects all the way: ML skills across the board, development and infrastructure, project and stakeholder management.
- Creator of the melAInoma model and former ML manager RaySearch Laboratories
- Commercialized the world first ML product for automated radiation planning
- Adjungerad Professor i oftalmologi
- Forskargruppsledare
- M.D. Ph.D. FEBO
- Specialistläkare i ögonsjukdomar
- Specialistläkare i klinisk patologi
- Sektionschef Klinisk patologi, S:t Eriks Ögonsjukhus
- PhD Optimization of Radiation Therapy
- Background in medtech and financial services
- ML in cancer radiation treatment of 1000s of patients
- Director of Machine Learning at RaySearch Laboratories
- Image analysis, ML engineering, AI regulatory affairs
- PhD computational neuroscience
- Background in financial services and pharma.
- CEO Söderberg & Partners China.
- Freelance consultant AI & data engineering 2016-24.
- Time series, image processing, LLM, recommender systems
